WASHINGTON, D.C. – Today, U.S. Reps. Mike Carey (R-Ohio-15), a member of the House Ways and Means Committee, Greg Landsman (D-Ohio-01), and Max Miller (R-Ohio-07) introduced the Infertility Treatment Affordability Act. This legislation will help create a new tax credit for parents undergoing infertility treatments in the effort to start and grow American families.
“Our bipartisan tax legislation makes it easier for families to grow and directly matches other pro-family policies. It gives parents more financial freedom to choose the best way to have children,” Rep. Carey said. “Having a family is the greatest blessing I’ve ever received, and making it easier to start or grow your family is a noble pursuit included in the American Dream. I ask that my colleagues join me in this bipartisan, pro-family effort.”
“When families are struggling to have a child, they shouldn’t have to worry about how they’ll afford the care they need,” Rep. Landsman said. “This tax credit gives them real options – without the fear of overwhelming costs – and the ability to choose the treatment that’s right for them with their doctor.”
“Every American deserves the opportunity to build a family, and that shouldn’t be limited by income, geography, or insurance coverage. The Infertility Treatment Affordability Act is a compassionate, commonsense solution that provides financial relief to families facing the emotional and economic challenges of infertility,” Rep. Miller said. “By creating a tax credit modeled after the Adoption Tax Credit, this bill gives hope to families who are anxiously waiting to have a child, and I’m proud to support it.”
“As a company that was here for the first IVF baby and more than 6 million globally since then, EMD Serono supports all actions that aim to remove barriers to accessing fertility treatments,” Miguel Fernández Alcalde, President of EMD Serono, said. “We applaud Representatives Carey, Landsman, and Miller for working across the aisle to alleviate the financial burden of infertility treatments, and we look forward to our continued collaboration to support those trying to build a family.”
“For the past 50 years, RESOLVE has worked tirelessly alongside our patient community to reduce barriers to family building. We know the biggest barrier that families face are out-of-pocket medical costs, and we thank Representatives Carey and Landsman for fighting to ensure that more Americans can build the family they deserve,” Danielle Melfi, CEO of RESOLVE: The National Infertility Association, said.
“Ferring strongly supports efforts at the state and federal level to expand access to assisted reproductive technologies, such as in vitro fertilization (IVF). We are very encouraged to see the bipartisan Infertility Treatment Affordability Act led by Congressmen Carey and Landsman to help aspiring parents manage the cost of this proven scientific innovation through a tax credit. With 1 in 6 people around the world experiencing infertility, IVF is a necessary medical treatment that’s helping aspiring parents achieve their dream of parenthood. For more than 50 years, Ferring has been deeply committed to addressing the needs of aspiring parents. We thank Congressmen Carey and Landsman for their leadership on helping people to build their families and look forward to continuing to work with them to advance the Infertility Treatment Affordability Act,” Brent Ragans, U.S. President of Ferring Pharmaceuticals, said.
BACKGROUND:
The Infertility Treatment Affordability Act establishes a tax credit that is partially refundable up to $5,000 (indexed for inflation) beginning in taxable years starting after December 31, 2024. Eligible individuals can receive a tax credit equal to 50% of the qualified infertility treatment expenses paid during the taxable year.
The tax provisions of this bill directly mirror the provisions of the adoption tax credit included in the Republican reconciliation law, which was signed on July 4, 2025.
Full text of the bill can be found here.
# # #